The COVID-19 pandemic and the use of MS disease-modifying therapies
Volume: 39, Pages: 102073 - 102073
Published: Apr 1, 2020
Abstract
Maria was distraught after reading about the ‘potential’ epidemic, yet to happen, and the horror stories on Facebook needing reassurance and certainty about what she should do. She requested an urgent appointment to review her treatment plan. Maria was a 26-year-old woman with relapsing multiple sclerosis who had recently experienced brainstem relapse with double vision and ataxia despite treatment with pegylated interferon-beta for the last 18...
Paper Details
Title
The COVID-19 pandemic and the use of MS disease-modifying therapies
Published Date
Apr 1, 2020
Volume
39
Pages
102073 - 102073
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History